TXG: 10x Genomics, Inc. Operatsion marja

10xgenomics.com (TXG) kompaniyasining rasmiy ramzlari

Zavod quvvatlarining barqaror foydalanishi va robototexnika tizimlarining yangilanishi 10x Genomics, Inc. (TXG) uchun hujayralarni tahlil qilish tizimlarining uzluksiz ishlab chiqarilishini kafolatlaydi. Operatsion marja tendentsiyasi ushbu jarayonni aks ettiradi, bunda -11.50 ko'rsatkichi ushbu darajani belgilaydi. Prostral biologiya sohasidagi ustunlik va patent himoyasi 10x Genomics, Inc. (TXG) ga narxlarni belgilash imkoniyatini beradi, onkologiya va neyrobiologiya markazlariga reagentlar yetkazib berish esa kompaniyaning biznes risklarini samarali diversifikatsiya qiladi.

TXG - 10x Genomics Inc Operatsion faoliyat rentabelligi 04.07.2022 - 19.11.2026 oraligʻida

10x Genomics, Inc. (TXG) kompaniyasining tahliliy kesimlari

Kompaniyaning barcha koʻrsatkichlari tahlili:10x Genomics, Inc., TXG
10x brendining mahsuloti

10x Genomics, Inc. (TXG) kompaniyasining fazoviy biologiya sohasidagi yetakchiligi yuqori texnologik platformalarga ulkan investitsiyalarni talab qiladi. Operatsion marja operatsion foydani moliyaviy xarajatlar va soliqlardan oldingi daromad bilan solishtirish orqali ushbu faoliyatlarning samaradorligini aks ettiradi. Ushbu koeffitsient biznesning o'z asosiy siklidan foyda olish qobiliyatini o'lchaydi. Asosiy operatsiyalardan olingan marjinal daromadni tahlil qilish tendentsiyaning barqarorligini aniqlash imkonini beradi. Ushbu grafikni talqin qilishda xatarlarni e'tiborsiz qoldirish yo'qotishlarga olib keladi.

Raqobatdosh kompaniyalar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|NTLA (Intellia Therapeutics, Inc.) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Stoke Corp (STOK)|Operatsion faoliyat rentabelligi BioLife|Operatsion marja WVE (Wave Life Sciences Ltd)|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik